key: cord-1033707-hq41xa88 authors: Golin, Rachel; Godfrey, Catherine; Firth, Jacqueline; Lee, Lana; Minior, Thomas; Phelps, B. Ryan; Raizes, Elliot G.; Ake, Julie A.; Siberry, George K. title: PEPFAR’s Response to the Convergence of the HIV and COVID‐19 Pandemics in Sub‐Saharan Africa date: 2020-07-12 journal: J Int AIDS Soc DOI: 10.1002/jia2.25587 sha: 158f9e19780f79b7da0c10073dbde432f967d499 doc_id: 1033707 cord_uid: hq41xa88 INTRODUCTION: The COVID‐19 pandemic reached the African continent in less than three months from when the first cases were reported from mainland China. As COVID‐19 preparedness and response plans were rapidly instituted across sub‐Saharan Africa, many governments and donor organizations braced themselves for the unknown impact the COVID‐19 pandemic would have in under‐resourced settings with high burdens of PLHIV. The potential negative impact of COVID‐19 in these countries is uncertain, but is estimated to contribute both directly and indirectly to the morbidity and mortality of PLHIV, requiring countries to leverage existing HIV care systems to propel COVID‐19 responses, while protecting PLHIV and HIV program gains. In anticipation of COVID‐19‐related disruptions, PEPFAR promptly established guidance to rapidly adapt HIV programs to maintain essential HIV services while protecting recipients of care and staff from COVID‐19. This commentary reviews PEPFAR’s COVID‐19 technical guidance and provides country‐specific examples of program adaptions in sub‐Sahran Africa. DISCUSSION: The COVID‐19 pandemic may pose significant risks to the continuity of HIV services, especially in countries with high HIV prevalence and weak and over‐burdened health systems. Although there is currently limited understanding of how COVID‐19 affects PLHIV, it is imperative that public health systems and academic centers monitor the impact of COVID‐19 on PLHIV. The general principles of the HIV program adaptation guidance from PEPFAR prioritize protecting the gains in the HIV response while minimizing in‐person home and facility visits and other direct contact when COVID‐19 control measures are in effect. PEPFAR‐supported clinical, laboratory, supply chain, community and data reporting systems can play an important role in mitigating the impact of COVID‐19 in sub‐Saharan Africa. CONCLUSIONS: As community transmission of COVID‐19 continues and the number of country cases rise, fragile health systems may be strained. Utilizing the adaptive, data‐driven program approaches in facilities and communities established and supported by PEPFAR provides the opportunity to strengthen the COVID‐19 response while protecting the immense gains spanning HIV prevention, testing and treatment reached thus far. supply chain, community and data reporting systems can play an important role in mitigating the 23 impact of COVID-19 in sub-Saharan Africa. 24 25 Conclusions: As community transmission of COVID-19 continues and the number of country cases 26 rise, fragile health systems may be strained. Utilizing the adaptive, data-driven program approaches 27 in facilities and communities established and supported by PEPFAR provides the opportunity to 28 strengthen the COVID-19 response while protecting the immense gains spanning HIV prevention, 29 testing and treatment reached thus far. 31 Less than three months from the first reported cases of COVID-19 in China, the pandemic reached 32 Nigeria, the first sub-Saharan African country to report a confirmed case of COVID-19, at the end of 33 February 2020 [1] . COVID-19 response plans were rapidly developed and instituted as governments 34 and donor organizations braced themselves for the impact of COVID-19 in low-and middle-income 35 countries with high burdens of people living with HIV (PLHIV) [2, 3] . 36 Despite sweeping measures to mitigate COVID-19 transmission, as of 1 July 2020, 303,986 37 confirmed cases, and 6,155 deaths were reported across the World Health Organization's African 38 Region Member States [4] , including 11 countries with a >5% adult HIV prevalence [5] . Information 39 about the impact of HIV co-infection on COVID-19 transmission, morbidity and mortality is limited. inadequate [11] .The potential negative impact of COVID-19 in these countries is currently uncertain, 48 but COVID-19 is anticipated to contribute both directly and indirectly to the morbidity and mortality 49 of PLHIV, requiring countries to leverage existing resources and infrastructure to propel COVID-19 50 responses while protecting PLHIV and HIV program gains. Although it is unclear whether PLHIV have increased risk of SARS-CoV-2 acquisition or progression 54 to severe disease [12] [15, 16] . Health systems strengthening efforts of large, successful public health programs 67 such as PEPFAR have been predominantly focused on outpatients, and significant gaps in critical care 68 capacity persist in low-and-middle income countries [17] . Of further concern, laboratory instruments, supplies and staff needed for HIV viral load (VL) 70 monitoring, early infant HIV diagnosis (EID), and tuberculosis testing may be diverted to SARS- CoV-2 testing. The net result will be a dangerous inability to meet the prevention, testing, and 72 treatment needs for either HIV or COVID-19. In the West Africa experience with Ebola, modeling 73 suggests more deaths were attributed to disruptions in HIV, TB, and malaria services than directly to 74 Ebola infection [18] . 75 As in the West African Ebola outbreak [18] , fears of healthcare-associated transmission may 76 exacerbate healthcare worker shortages and discourage people from seeking crucial HIV services at 77 facilities. Additionally, healthcare workers have been disproportionately impacted by COVID-19 due 78 to insufficient quantities of personal protective equipment and resulting exposure [19] . COVID-19 79 mitigation strategies are limiting importation and distribution of critical health commodities required 80 for essential HIV services [20] . Furthermore, concerns have been raised that COVID-19 plans will 81 divert resources from HIV, TB, and malaria programs [21] . 83 In anticipation of these disruptions, PEPFAR established guidance to rapidly adapt HIV programs to 84 maintain essential HIV services while protecting recipients of care and staff from COVID-19. The 85 general principles prioritize protecting recent gains in the HIV response while minimizing exposure to 86 COVID-19 at healthcare facilities and reducing the burden on these facilities [22] [23] [24] . Congruent to 87 recent advocacy by the International AIDS Society [25] , there is special emphasis on continuity of reported increases in domestic violence [26] and can increase child protection risks [27] . Orphans, 98 vulnerable children, adolescent girls, and young women (AGYW) have been prioritized to receive 99 virtual risk screening and linkage to essential services, including referrals if at risk for or experiencing 100 abuse, neglect, or violence. Specific guidance has been provided on how to deliver virtual support to 101 beneficiaries of PEPFAR's Determined, Resilient, Empowered, Mentored, and Safe (DREAMS) 102 program for AGYW [28] . In response to reduced access to facility-based services, strategic adaptions to testing services include 126 leveraging private public partnerships and community platforms for distribution of HIV self-testing 127 kits in accordance with national guidance. Decentralized distribution of HIV self-testing kits has 128 provided a valuable platform to broaden COVID-19 health messaging, screening, and contact tracing. HIV self-testing is also being leveraged to assist with index testing, especially in settings where active In response to ongoing concern over the unknown economic impact of COVID-19 among vulnerable Aligned with host countries' needs, PEPFAR's current human resources for health (HRH) strategy utilization, investing in HRH retention, service quality improvements, and sustainable financing for 216 healthcare workers who deliver HIV services [29] . PEPFAR has supported nearly 300,000 healthcare 217 workers at more than 3,000 laboratories and 70,000 health facilities [30] . PEPFAR-supported health 218 workers, lab personnel, supply chain advisors, and policy makers have equipped countries to be able 219 to respond to HIV and emerging infectious diseases such as COVID-19. The COVID-19 pandemic 220 has required mobility and flexibility in service delivery teams, with task sharing and redeployment in COVID-19 Situation Update for the WHO African Region, External Situation Report 1 COVID-19 Virus Readiness Situation Update Africa in the Path of COVID-19 World Health Organization, Regional Office for Africa. COVID-19 in the WHO African Region The Joint United Nations Programme on HIV/AIDS (UNAIDS). Countries [Internet Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV and HCV Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19) Accepted Article This article is protected by copyright. All rights reserved COVID-19 in patients with HIV: Clinical Case Series COVID-19 Special Public Health Surveillance Bulletin New WHO Estimates: Up to 190 000 people could die of COVID-19 in Africa if not controlled COVID-19 and HIV: What you need to know Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) -United States Index Mundi from World Health Organization. Hospital beds (per 1,000 people) -Country Ranking Index Mundi from World Health Organization. Nurses and midwives (per 1,000 people) -Country Ranking Index Mundi from World Health Organization. Physicians (per 1,000 people) -Country Ranking Current challenges in the management of sepsis in ICUs in resource-poor settings and suggestions for the future Effects of Response Emerg Infect Dis The coronavirus is jeopardizing a "very, very" finite workforce: Africa's doctors and nurses. The Washington Post United Nations Economic Commission for Africa. COVID-19 in Africa Protecting Lives and Economies How COVID-19 must transform US global health strategy. The Hill The United States President's Emergency Plan for AIDS Relief (PEPFAR) The United States President's Emergency Plan for AIDS Relief (PEPFAR) COVID-19 & PEPFAR: Implications for the Future The time is now: expedited HIV differentiated service delivery during the COVID-19 pandemic As Cities Around the World Go on Lockdown, Victims of Domestic Violence Look for a Way Out Technical Note: Protection of Children during the Coronavirus Pandemic, Version 1 Virtual Delivery of DREAMS Content During COVID-19 Annual Report to Congress Lost Time: Recovering from COVID-19's Impact on the Global HIV Response Office of HIV/AIDS. Partner Operational Solutions in Response to COVID-19: Facility-based Staffing Solutions Contributions: None This article is protected by copyright. All rights reserved The authors declare no competing interests. The initial concept for this commentary was conceived by GKS. RG, CG, TM, BRP and GKS contributed to the initial outline. All authors contributed to the initial manuscript content. RG, CG, BRP, ER and GKS contributed to the revisions. All authors reviewed and approved the final commentary.